Who founded Co-Diagnostics?

Co-Diagnostics was founded by Brent Satterfield, Dwight Egan in 2013.

How much funding has Co-Diagnostics raised?

Co-Diagnostics has disclosed $47.3M raised across 2 rounds.

Where is Co-Diagnostics headquartered?

Co-Diagnostics is headquartered in Salt Lake City, US.

Co-Diagnostics

NASDAQ: CODX

Salt Lake City, US · Founded 2013 · Utah corporation

Find your way into Co-Diagnostics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Co-Diagnostics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Co-Dx develops real-time PCR diagnostic tests and a portable qPCR platform for use at home, in businesses, and at point-of-care facilities. Its testing solutions, powered by proprietary Co-Primers technology, target infectious diseases and are offered as in vitro diagnostic and research-use products.

Biotech Digital Health Medical Devices

Founders & leadership

Co-Diagnostics was founded in 2013 by Brent Satterfield and Dwight Egan.

Brent SatterfieldCo-founder

Dwight Egan Chief Executive Officer, President and Chairman of the BoardDwight Egan co-founded Co-Diagnostics and has served as CEO since inception. Previously, he was a senior executive at Data Broadcasting Corporation, a wireless financial data provider, and co-founded and led Broadcast International, which was acquired in 1995 to form CBS MarketWatch.

Reed L. BensonExecutive

Brian BrownChief Financial Officer and Secretary

Richard AbbottPresident

Reported raises · per SEC filings

Form D private placements

$47.3M disclosed across 2 rounds · 2016–2021

▶$46.6MraisedJan 2022 · 22 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Brian BrownExecutive Officer
Dwight EganExecutive Officer

Offering amount: $47.2M
Amount sold: $46.6M
First sale: Dec 2021
Incorporated: Corporation, Utah
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$750KraisedDec 2016 · 11 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Reed L. BensonExecutive Officer, Director
Dwight H. EganExecutive Officer
Brent SatterfieldDirector

Amount sold: $750K
First sale: Dec 2016
Incorporated: Corporation, New York, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events

$66.4Mvaluation at IPOJul 2017 · $6.00/share · 424B4

filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Frequently asked questions

What does Co-Diagnostics do?: Co-Dx develops real-time PCR diagnostic tests and a portable qPCR platform for use at home, in businesses, and at point-of-care facilities. Its testing solutions, powered by proprietary Co-Primers technology, target infectious diseases and are offered as in vitro diagnostic and research-use products.
Who founded Co-Diagnostics?: Co-Diagnostics was founded by Brent Satterfield, Dwight Egan in 2013.
How much funding has Co-Diagnostics raised?: Co-Diagnostics has disclosed $47.3M raised across 2 rounds.
Where is Co-Diagnostics headquartered?: Co-Diagnostics is headquartered in Salt Lake City, US.